ultra potent-C 1000 by metagenics is an exclusive, patented formula designed to enhance the utilization of vitamin c. preliminary scientific research suggests that vitamin c in the form of ultra potent-c may result in improved uptake by white blood cells when compared to regular ascorbic acid.* 90 tablets
Description
ultra potent-C 1000 by metagenics is an exclusive, patented formula designed to enhance the utilization of vitamin c. preliminary scientific research suggests that vitamin c in the form of ultra potent-c may result in improved uptake by white blood cells when compared to regular ascorbic acid.* 90 tablets
to use: take one tablet three times daily or as directed by your healthcare practitioner.
ingredients:
serving size:
1 tablet
ingredient | amount | daily value |
vitamin c (as ultra potent-c®†) | 500 mg | 833% |
niacin (as niacinamide ascorbate) | 39 mg | 190% |
calcium (as calcium ascorbate) | 24 mg | 2% |
magnesium (as magnesium ascorbate) | 3 mg | <1% |
sodium (as sodium ascorbate) | 7 mg | <1% |
potassium (as potassium ascorbate) | 3 mg | <1% |
l-lysine hci | 18 mg | * |
citrus bioflavonoid complex [standardized to 45% (8 mg) full spectrum bioflavonoids] | 18 mg | * |
tetrasodium pyrophosphate | 8 mg | * |
alpha d-ribofuranose | 7 mg | * |
xylitol | 5 mg | * |
l-cysteine | 5 mg | * |
l-glutathione | 3 mg | * |
other ingredients: ultra potent-c® [calcium ascorbate, niacinamide ascorbate, ascorbic acid, sodium ascorbate, magnesium ascorbate, l-lysine hci, ascorbyl palmitate, citrus bioflavonoid complex, potassium ascorbate, tetrasodium pyrophosphate, alpha d-ribofuranose, l-cysteine hci, xylitol, and l-glutathione], microcrystalline cellulose, cellulose, stearic acid (vegetable), croscarmellose sodium, magnesium stearate (vegetable), and coating (water, hypromellose, medium chain triglycerides , and hydroxypropylcellulose).
Additional information
Weight | 4 oz |
---|---|
Dimensions | 2 × 2 × 4 in |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.